Remote Diagnostics: 

Seeing Eye Health Differently  

Topcon Healthcare

© 2020  Topcon Healthcare 

 111 Bauer Drive, Oakland, NJ 07436


Clinicians have been forced to rethink patient care due to COVID-19. The pandemic has also forced industry leaders to think of how they can support doctors, their staff, and their patients amidst the changing landscape in clinical practice. Esteemed thought leaders in Ocular Telehealth, Lama AI-Aswad, MD, Mingguang He, MD, PhD, Paul Testa, MD, JD and Karl Mercieca, MD will set out the issues currently faced by clinicians. Together, they challenge Topcon Healthcare Executive, John Trefethen – VP, Marketing & Product Design, to provide smart solutions for today and the future. 


Lama Al-Aswad, MD    |   Panelist

Lama A. Al-Aswad, MD, MPH is an ophthalmologist with a subspecialty in glaucoma and cataract, with a strong interest in disease prevention and population health management. She is a professor of ophthalmology at NYU Langone Health, and the Vice Chair for Innovations and the Director of Teleophthalmology, Artificial Intelligence and Innovations, and the Associate director of the glaucoma fellowship. She received her medical degree from Damascus University Medical School and completed her glaucoma research fellowship at the Mass Eye and Ear Infirmary, Harvard Medical School. Subsequently, she completed her residency in ophthalmology at the SUNY Downstate and her glaucoma fellowship at the University of Tennessee.

John Trefethen, MFA   |    Panelist

John Trefethen, MFA, is a marketer and educator with over 25 years of technology, education, marketing, and design experience. He is currently serving as Topcon's Vice President of Global Marketing and Product Design, where he oversees the strategic development, implementation and marketing of new products and solutions to the global eye care community.

Mingguang He, MD, PhD    |   Panelist

Mingguang He, MD, PhD, is currently Professor of Ophthalmic Epidemiology at the University of Melbourne and Centre for Eye Research Australia and Director of WHO Collaborating Centre for Prevention of Blindness (Australia). He has worked in China for more than 20 years and was the former Associate President and Professor of Ophthalmology in the Zhongshan Ophthalmic Center (ZOC), Sun Yat-sen University. He founded and served as the first president of the Asia Pacific Tele-Ophthalmology Society and has successfully organized annual meetings in Beijing, Hong Kong, Singapore and most recently in Chennai. He ran the first real-world study on deploying artificial intelligence to enable diabetic retinopathy screening at endocrinology and primary care settings in Australia and China. His research has been published in more than 350 publications, and he has been a senior author in peer-reviewed journals, including JAMA and Lancet.

Paul Testa, MD, JD   |   Panelist

Paul Testa, MD, JD, is the Chief Medical Information Officer at NYU Langone Health. In this capacity, Dr. Testa serves as the clinical informatics physician leader; stewards industry-leading telemedicine initiatives; and shepherds programs in the areas of clinical quality, data management, predictive analytics and informatics research. Dr. Testa also serves as an Assistant Professor in the Ronald O. Perelman Department of Emergency Medicine at NYU Langone Health. He lectures and publishes on topics in health care information technology, risk management, regulatory compliance, and emergency medicine. Prior to entering the field of clinical medicine, Dr. Testa practiced law in New York and Boston providing counsel to academic medical centers. After graduating from Middlebury College in Vermont, he earned a JD at Boston College Law School, a MD at Dartmouth Medical School, and a Masters of Public Health with a concentration in public health law at Harvard University.

Karl Mercieca, MD  |   Panelist

Karl Mercieca, MD, is a consultant ophthalmologist and glaucoma surgeon at Manchester Royal Eye Hospital, UK. He is also honorary senior lecturer at Manchester University and glaucoma co-lead for the MSc in Investigative Ophthalmology and Visual Sciences degree in addition to being co-chair of the European Glaucoma Society sub-speciality training and exams committee. Karl is highly active in ophthalmology research as evidenced by over 30 publications in peer-reviewed journals. He has received several research prizes including best poster prize at the American Academy of Ophthalmology congress and the Peter Watson medal for highest score in the FEBO glaucoma sub-speciality exam. His research portfolio includes studies on CSF pulsatility, vascular biomarkers, non-penetrating glaucoma surgery and uveitic glaucoma. 


Get Instant Access to Watch Now